Cancer progression: is inhibin alpha from Venus or Mars?
Ball
Emma M A
EM
Centre for Urological Research, Monash Institute of Reproduction and Development, Monash University, 246 Clayton Rd, Clayton, Vic. 3168, Australia.
Mellor
Sally L
SL
Risbridger
Gail P
GP
D000818:Animals; D002273:Carcinogens / Q000378:metabolism; D018450:Disease Progression; D005260:Female; D016147:Genes, Tumor Suppressor / Q000502:physiology; D006801:Humans; D007265:Inhibins / Q000235:genetics / Q000378:metabolism*; D008297:Male; D051379:Mice; D008954:Models, Biological; D009363:Neoplasm Proteins / Q000378:metabolism; D009369:Neoplasms / Q000378:metabolism; D010051:Ovarian Neoplasms / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000378:metabolism*; D012720:Severity of Illness Index; D016212:Transforming Growth Factor beta / Q000235:genetics / Q000378:metabolism*
D002273:Carcinogens; D009363:Neoplasm Proteins; D016212:Transforming Growth Factor beta; C094377:inhibin-alpha subunit; D007265:Inhibins